With the pandemic emergence of SARS-CoV-2, the exposure of cell
substrates used for manufacturing of medicines has become a possibility.
Cell lines used in biomanufacturing were thus evaluated for their
SARS-CoV-2 susceptibility, and the detection of SARS-CoV-2 in culture
supernatants was tested by routine adventitious virus testing of
fermenter harvest.